Thrombogenicity of antihemophiliac preparations with factor VIII inhibitor bypassing activity.
D000818:Animals; D001777:Blood Coagulation / Q000187:drug effects*; D001779:Blood Coagulation Factors / Q000494:pharmacology; D005164:Factor IX / Q000494:pharmacology*; D015949:Factor IXa; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D051381:Rats; D011919:Rats, Inbred Strains
D001779:Blood Coagulation Factors; C025667:prothrombin complex concentrates; D005164:Factor IX; D015949:Factor IXa